Ocular Hypertension Completed Phase 2 Trials for Latanoprost (DB00654)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01917383A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaTreatment
NCT01318252AL-54478 Proof of Concept StudyTreatment
NCT02057575Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular PressureTreatment
NCT01379144A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionTreatment
NCT01731002Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureTreatment
NCT02179008Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionTreatment
NCT00650338Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionTreatment
NCT00620256Adjunctive Study of AL-37807 Ophthalmic SuspensionTreatment
NCT00572455Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.Treatment
NCT02083289A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)Treatment
NCT00595101A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.Treatment
NCT00465621Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01037036A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGTreatment
NCT00934089A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329Treatment
NCT00821002A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)Treatment
NCT00761709Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01254370Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface DiseaseTreatment
NCT01302249AR-12286 in Combination With LatanoprostTreatment
NCT01896180Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by LatanoprostTreatment
NCT00069706Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsTreatment
NCT00441883Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for GlaucomaTreatment
NCT00287521A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment